Overview
Biotech
NASDAQ-listed biotech developing non-hallucinogenic neuroplastogens via their Psybrary drug discovery platform. Lead candidate EB-003 targets PTSD and depression without psychoactive effects.
Visit Website0
Open Roles
Open Positions
No open positions at this time
Clinical Pipeline
No clinical trials on record